[ad_1]
High efficiency present the first russian vaccine against coronavirus, supports the fund that finances its development.
In particular, Sputnik V appeared 92% efficiency, as Russia claims.
Nowadays, 40,000 volunteers participate in the double-blind, randomized, placebo-controlled study in phase 3 trials.
More than 20,000 of them have already received it first part of the vaccine, while more than 16,000 also received the first Y second dose.
“Trials have shown efficacy among more than 16,000 volunteers who received the vaccine or placebo 21 days after the first dose.” As a result of a statistical analysis of 20 confirmed coronavirus cases, it appears that the Sputnik V vaccine had a rate of 92% efficacy after second dose, “states the press release, as Sputnik writes.
It is also observed that the volunteer tracking it will continue for another six months and then the full report will be presented.
“We are telling them, based on the data, that we have a very effective vaccine,” said Kirill Dmitriev, director of the Russian fund that supports the development and commercialization of the vaccine (RDIF), according to The Independent.
The announcement comes a few days later the companies Pfizer Inc and BioNTech announced that the experimental Covid-19 vaccine they are developing is more than 90% effective.
The two companies behind the formulation described their findings as “Beautiful day for science and humanity “.
The vaccine was tested on 43,500 people in six countries without worrying about security of those who received it, broadcasts the BBC.
The two companies, in fact, plan to present request for urgent approval of the use of the vaccine by end of the month.
Ankara is interested in producing the Russian Sputnik V vaccine
Turkey interested in producing The first Russian vaccine against the coronavirus, Sputnik V, in its own facilities, was announced today by the Russian Ministry of Health after a telephone conversation between the health ministers of the two countries.
Russia is already trying two vaccines against the virus and preparing to register a third party. Makes Sputnik V vaccine available for domestic use, even though the tests of the last phase have not finished yet.
“The head of the Turkish Ministry of Health has expressed interest in organizing the production of Sputnik V vaccine in Turkish pharmaceutical facilities, after conducting toxicological studies, as required by national legislation,” the Ministry of Health said in a statement. .
Russian Health Minister Mikhail Murasko assures the Turkish counterpart Russia is ready to carry out such tests, the statement read.
The Turkish Ministry of Health refused to confirm However, Health Minister Fahrettin Koca confirmed that the two men had a phone conversation with him, which he posted last night, Tuesday night, on Twitter.
“We exchanged views on health issues that we work on together, mainly on the efforts for a Covid-19 vaccine and the international companies in which we are involved,” Kotza said.
[ad_2]
